Regulatory & Legal

Remus Bourbon's Master Distiller Ian Stirsman pushes boundaries with Series No. 2, a 113-proof straight wheat whiskey finished in a symphony of port and sherry casks.

A strategic deal sees automotive safety tech repurposed for a booming defense market, targeting threats where traditional optical sensors fail.

As price wars and new tech reshape telecom, Cogeco's CEO will outline the firm's strategy for growth, fiber expansion, and its new flanker brands.

PainTEQ's landmark deal, crowned 'Deal of the Year,' showcases a new model for medtech growth and its patient-first mission in pain management.

Struggling mobile gaming platform Skillz brings in ex-Niantic CFO Jeff Shouger as an advisor, signaling a major push for financial discipline and growth.

Automotive supplier Martinrea's new report reveals major progress on sustainability goals, slashing emissions and waste while setting a competitive pace.

REPKON USA rebrands as Paligen, signaling a new era of domestic defense manufacturing fueled by a landmark TNT contract and strategic acquisitions.

A new report shows automakers are racing to innovate with AI, but a troubling decline in safety standard adherence puts the industry at a critical crossroads.

A new AI biomarker analyzes blood vessels in CT scans, offering earlier, more accurate predictions of which patients will benefit from immunotherapy.

Promising results for bladder cancer therapy TARA-002, key FDA designations, and a $198M cash runway position Protara for a pivotal year.

With NCQA Prevalidation for its ARC platform, COPE Health Solutions offers health plans a streamlined path to accreditation and a trusted tool for VBC.

The insurer posted strong 2025 results, with core underwriting gains and niche market growth overshadowing a $15.7 million hit from California fires.

In a strategic move to fortify national security, X-Bow is acquiring Evolution Space, boosting US rocket motor production and hypersonic capabilities.

Quantum firm Zapata adds industry veterans to its board, signaling a strategic shift in the quantum race from hardware supremacy to software application.

With its novel glaucoma drug QLS-111 entering Phase 3, Qlaris Bio brings in seasoned leader Fred Guerard to navigate the final trials and path to market.

With its CAR-T therapy achieving franchise profitability and treating 10,000 patients, Legend Biotech eyes overall profit and next-gen cancer treatments.

PowerBank Corp. secures millions in state funding to build a community solar farm on a former industrial site, promising lower energy bills for 875 homes.

Celebrating 80 years, Aveeno renews its foundational ties with Mayo Clinic, launching a new era of oat science research for compromised skin.

A landmark deal between Diverso and Dandelion Energy aims to make geothermal a standard utility in new homes, removing cost barriers for builders and buyers.

A new industry report claims mining for green minerals is low-emission, but reveals the real climate fight is decarbonizing steel and aluminum production.